1. Home
  2. RDHL vs ATXG Comparison

RDHL vs ATXG Comparison

Compare RDHL & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • ATXG
  • Stock Information
  • Founded
  • RDHL 2009
  • ATXG 2014
  • Country
  • RDHL Israel
  • ATXG China
  • Employees
  • RDHL N/A
  • ATXG N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • ATXG Professional Services
  • Sector
  • RDHL Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • RDHL 3.9M
  • ATXG 3.8M
  • IPO Year
  • RDHL N/A
  • ATXG N/A
  • Fundamental
  • Price
  • RDHL $1.57
  • ATXG $0.68
  • Analyst Decision
  • RDHL
  • ATXG
  • Analyst Count
  • RDHL 0
  • ATXG 0
  • Target Price
  • RDHL N/A
  • ATXG N/A
  • AVG Volume (30 Days)
  • RDHL 1.5M
  • ATXG 406.2K
  • Earning Date
  • RDHL 09-05-2025
  • ATXG 11-13-2025
  • Dividend Yield
  • RDHL N/A
  • ATXG N/A
  • EPS Growth
  • RDHL N/A
  • ATXG N/A
  • EPS
  • RDHL N/A
  • ATXG N/A
  • Revenue
  • RDHL $9,550,000.00
  • ATXG $4,310,835.00
  • Revenue This Year
  • RDHL $381.91
  • ATXG N/A
  • Revenue Next Year
  • RDHL N/A
  • ATXG N/A
  • P/E Ratio
  • RDHL N/A
  • ATXG N/A
  • Revenue Growth
  • RDHL 157.62
  • ATXG N/A
  • 52 Week Low
  • RDHL $1.06
  • ATXG $0.36
  • 52 Week High
  • RDHL $8.75
  • ATXG $1.86
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 43.92
  • ATXG 35.56
  • Support Level
  • RDHL $1.64
  • ATXG $0.61
  • Resistance Level
  • RDHL $1.90
  • ATXG $0.72
  • Average True Range (ATR)
  • RDHL 0.16
  • ATXG 0.10
  • MACD
  • RDHL -0.03
  • ATXG -0.05
  • Stochastic Oscillator
  • RDHL 10.94
  • ATXG 15.79

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: